Toll-Like Receptors are critical in controlling colonic inflammation and cancer
2011

The Role of SIGIRR in Colonic Inflammation and Cancer

publication

Author Information

Author(s): Xiao Hui, Yin Weiguo, Khan Mohammed A, Gulen Muhammet F, Vallance Bruce A, Li Xiaoxia

Primary Institution: Institut Pasteur of Shanghai

Hypothesis

The study investigates the role of SIGIRR in regulating TLR signaling and its impact on colonic tumorigenesis.

Conclusion

The study found that SIGIRR is a critical tumor suppressor that controls tumorigenesis by inhibiting TLR-induced mTOR and NFkB pathways in the colonic epithelium.

Supporting Evidence

  • Lack of SIGIRR led to increased genetic instability and colonic polyposis in mice.
  • Elevated colonic tumorigenesis in mice was dependent on commensal microbes.
  • SIGIRR modulates TLR-mediated tumor initiation through the Akt-mTOR axis.
  • Rapamycin prevented microadenoma and polyp formation in the studied mice.
  • Re-expression of SIGIRR ameliorated intestinal tumorigenesis.

Takeaway

This study shows that a protein called SIGIRR helps prevent cancer in the gut by controlling how the body responds to germs.

Methodology

The study used Apcmin/+/Sigirr-/- mice to investigate the effects of SIGIRR on tumorigenesis and TLR signaling.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication